The cleavage of DNA by esperamicin is greatly accelerated in the presence of thiol compounds. Oxygen and active oxygen-radical scavengers have no significant influence upon DNA strand breakage by esperamicin. The preferential cutting sites of esperamicin are at thymidylate residues, and the frequency of bases attacked
bicyclo [7.3.1] tridecane system that combines a methyl trusulfide and double and triple bonds in a 3-ene-1,5-diyne relationship. The unique structures of the antibiotics appear to contribute to their extreme potency as antitumor agents. Esperamicin preferentially inhibits DNA synthesis (3) in the mouse leukemia cell line L1210. Of special interest in this regard is a proposal that the esperamicin/calicheamicin antibiotics may belong to a new class of DNA-damaging agents (1) (2) (3) (4) (5) .
It is well known that bleomycin attacks DNA deoxyribose through the intermediacy of a reactive, reduced form of oxygen and cleaves preferentially at guanine-pyrimidine (5' 3') sequences, in particular GC sites (6, 7) . Recently, a minor-groove interaction model of metallobleomycin in the DNA helix was developed by computer-constructed model building (8) . In contrast, neocarzinostatin is itself converted into a diradical that directly attacks the deoxyribose of mainly thymidylate residues in DNA (9) (10) (11) (12) (13) (14) . Herein, we report that esperamicin clearly exhibits sequence-specific DNA breakage and minor-groove interaction. The present results were also compared with those for bleomycin and 
MATERIALS AND METHODS
Drugs and Chemicals. Esperamicins A1, C, and D, distamycin A, and the Acc I-Acc II DNA fragment of plasmid pUC19 were gifts of Bristol-Myers, F. Arcamone (Farmitalia), and T. Komano (Kyoto University, Kyoto, Japan), respectively. tTo whom reprint requests should be addressed.
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EcoRP restriction endonuclease was obtained from Takara Shuzo (Kyoto, Japan). Netropsin and actinomycin D were purchased from Sigma. All other chemicals used were of commercial reagent grade.
DNA Cleavage Reaction. The reaction samples (total volume, 20 t4) contained 0.6 pg of pBR322 plasmid DNA, 1 mM deferoxamine, 10 mM EDTA (adjusted to pH 8.0), and 10 mM Tris/HCl buffer (pH 7.5). Deferoxamine and EDTA were included to avoid the influence of contaminating metal ions such as iron. The cleavage reaction was initiated by addition of dithiothreitol (0.1 mM), and the samples were incubated at 370C. The reactions were stopped by addition of cold ethanol (70 p.l) and 3 mM sodium acetate, and then the samples were immediately chilled at -700C in a dry ice/ethanol bath. Each lyophilized sample was dissolved in 25 ttl of loading buffer containing 0.05% bromophenol blue and 10% glycerol and heated at 60'C for 1 min before electrophoresis. Electrophoresis was performed using 1% agarose gel containing ethidium bromide (0.5 pg/ml). Nucleotide Sequence Analysis. The reaction samples (total volume, 20 ,ul) contained the 5'-end-labeled 322-base pair DNA fragment (pUC19 Acc I-Acc II), sonicated calf thymus DNA (225 p.M base), 1 mM deferoxamine, 10 mM EDTA, and 10 mM Tris/HCl buffer (pH 7.5). The nucleotide sequence cleavages were initiated by addition of esperamicin (50 ,uM) and diothiothreitol (0.5 mM), and then the samples were incubated at 37°C for 15 min. Cold ethanol was added to the sample solutions in order to stop the reaction. Electrophoresis was performed in a 10% polyacrylamide/7 M urea slab gel at 1500 V for 4 hr. DNA sequencing was carried out by the Maxam-Gilbert method (15) .
RESULTS
DNA Cleavage by Esperamicin Al. Fig. 2 shows typical gel electrophoretic patterns for esperamicin-mediated strand scission of covalently closed, supercoiled (form I) pBR322 DNA. In the presence of dithiothreitol, esperamicin markedly stimulated DNA breakage to form open-circular (form II) and linear (form III) DNAs even at the reaction time of 1 min. At 10-120 min, extensive fragmentation of DNA was clearly observed (Fig. 2, lanes 5-8) . Fig. 3 displays the effect of reducing agents on the DNA cleavage by esperamicin A1. Sodium borohydride, NADPH, and L-ascorbic acid had no significant effect on the DNA cleavage reaction. Only the sulfur-containing reducing agents had an effect, clearly accelerating the cleavage process. Effects of Oxygen and Radical Scavengers. Deaeration was achieved by purging the sample Tunberg cuvette with argon gas and then evacuating for 5 min. Fig. 4 shows that oxygen had a negligible effect on the primary DNA strand breakage by esperamicin A1. Under the same experimental conditions, the DNA cleavage activity of the peplomycin-iron complex was markedly inhibited by deaeration (lanes 6 and 7). It is well known that bleomycin antibiotics require iron and oxygen as cofactors for strong DNA cutting (16) . Further, we checked the effect of some active oxygen-radical scavengers. The breakage of DNA by esperamicin was not affected appreciably by addition of superoxide dismutase (0.1 mg/ml, 300 units/ml), catalase (10 ,pg/ml, 450 units/ml), mannitol (1
Tiron (1,2-dihydroxy-3,5-benzenedisulfonate, 1 mM). These results strongly indicate that oxygen and active oxygenradical species do not participate in DNA strand scission by esperamicin antibiotics.
Nucleotide Sequence-Specific Cleavage. (16) . It has been established that malondialdehyde detected during bleomycin-mediated DNA degradation is produced from a product containing a nucleic acid base and a 3-carbon fragment derived from the deoxyribose ring and that the DNA cleavage by bleomycin is due to oxidative attack at the C-4' position of deoxyribose (6, 21) . A preliminary assay using thiobarbituric acid revealed high production of a malondialdehyde-like compound during esperamicin-mediated DNA degradation, as well as during bleomycin-mediated cleavage (data not shown). During DNA degradation by the o-phenanthroline-Cu+ complex, which has been proposed to attack at the C-1' position of deoxyribose, the formation of thiobarbituric acid reaction products is remarkably low (22) . Recent studies have postulated that neocarzinostatin (23) and calicheamicin (5) attack the C-5' position of deoxyribose. Therefore, DNA strand breakage by esperamicin may be due to oxidative attack at the C-4' and/or C-5' position of deoxyribose. To 19, 20) . Although the most preferred cutting site for esperamicin is also at thymidylate residues, the order of bases attacked (T > C > A > G) in the esperamicin reaction is clearly different from that (T > A > C > G) in the neocarzinostatin reaction. DNA cleavage by esperamicin is highly specific for pyrimidine bases. In addition, esperamicin preferentially attacks at T and C in oligopyrimidine regions such as 5'-CTC-3', 5'-TTC-3', and 5'-TTT-3' and in 5'-TG-3' and 5'-CG-3' sequences. Neocarzinostatin has no clear specificity for neighboring nucleotides, although in certain instances thymidylate residues in 5'-TG-3' sequences are favorable sites for strand scission (10) . Calicheamicin y, also preferentially attacks at C and T in oligopyrimidine regions such as 5'-TCC-3' and 5-CTC-3' (5). Similar specific cleavage at pyrimidine bases has been observed in the DNA strand scission by bleomycin (7). In the case of bleomycin antibiotics, the frequency of bases attacked is C > T > A > G and the preferred cutting sites are at 5'-GC-3' and 5'-GT-3' sequences.
Interaction of Esperamicin with the Minor Groove of DNA. As clearly shown in Fig. 5 , nucleotide-specific cleavage by esperamicin A1 is significantly affected by pretreatment of DNA with netropsin and distamycin A. These drugs are typical minor-groove binders and have A-T binding specificity (24) . Indeed, among the original cutting sites of esperamicin, the A+T-rich regions (5'-AATTCA-3', 5'-TTTTA-3', and 5'-AAAA-3') are strongly protected by netropsin and distamycin A. In contrast, these drugs enhance the cutting at two cytosines between 5'-AATTCA-3' and 5'-TTTTA-3' sequences, suggesting some changes of local DNA structure with the binding of netropsin or distamycin A. Certain cleavage sites such as 5'-GCTCG-3' and 5'-CCG-3' are also protected by the binding of actinomycin D, which is known to intercalate through C-G base pairs in the minor groove of DNA (25) . EcoRI endonuclease specifically recognizes the double-stranded sequence 5'-GAATTC-3' in the major groove of DNA (26) . The enzyme cuts at the EcoRI site in the presence of Mg2+ (Fig. 5, lane 13) . However, the binding of EcoRI gives no alterations in the cleavage pattern of esperamicin (Fig. 5, lane 12) . These results indicate that an interaction of esperamicin occurs via the minor groove of B-DNA. This is further supported by the asymmetric cleavage pattern staggered by 3 base pairs to the 3' side of DNA helix (Fig. 6 ) and suggests an orientation of the diyne-ene perpendicular to the plane of the base pairs in the helix. Pretreatment with distamycin A results in a large change in the sequence-specific DNA cleavage mode of bleomycin, which binds in the minor groove of B-DNA (8, 27) . In the bleomycin-DNA interaction, the 2-amino group of guanine adjacent to the 5' side of the cleaved pyrimidine is a key element of the specific 5'-GC-3' or 5'-GT-3' recognition (27) . Neocarzinostatin has also been proposed to intercalate in the minor groove of B-DNA (28) .
Structure-Activity Relationship of Esperamicins in DNA Cleavage. Esperamicin C lacks both the 2-deoxy-L-fucose and the aromatic ring moieties from esperamicin Al, and esperamicin D is similar to esperamicin C but also lacks the thiomethylhexapyranose moiety. Esperamicin C showed high cleavage activity similar to that of esperamicin Al, albeit at a 10-fold greater concentration. In addition, the sequencespecific breakage pattern of esperamicin C resembled very closely that of esperamicin A1. This result suggests that the fucose-anthranilate moiety does not contribute signficantly to base recognition by the esperamicin antibiotics, although it may have some effect on binding. The strong antitumor activity of esperamicin Al (4) suggests that the fucoseanthranilate group may favor increased uptake of the antibiotic by cells. Esperamicin D showed almost the same sequence-specific cleavage mode, although its DNA cleavage activity was considerably lower than those of esperamicins Al and C. This result indicates that the trisaccharide side chain of esperamicin plays an important role in the binding of esperamicin to DNA, while the diyne-ene moiety appears to be the key functional group for sequence-specific cleavage by the esperamicin antibiotics. The mechanism by which esperamicin degrades DNA has been suggested to involve bioreductive cleavage of the allylic trisulfide and Michael addition of the resultant thiolate to the neighboring bridgehead olefin (4, 5, 29), followed by diyne-ene cyclization to give a phenylene diradical. Therefore, the first step of DNA breakage in the minor groove may be abstraction of the C-4' or C-5' proton from deoxyribose units of thymidylate and deoxycytidylate residues by the phenylene diradical. With regard to the question of C-4' vs. C-5' oxidation, precise analysis of the cleavage products of esperamicin will be necessary.
In conclusion, esperamicin Al shows potent DNA-cleavage activity in the presence of sulfhydryl-containing compounds such as dithiothreitol, glutathione, and cysteine. In the esperamicin-mediated DNA degradation, thymidylate and deoxycytidylate residues in oligopyrimidine regions (5'-CTC-3', 5'-TTC-3', and 5'-TTT-3' sequences) are preferred cleavage sites. The frequency of bases attacked (T > C > A > G) is different from that of calicheamicin (C >> T > A = G), neocarzinostatin (T > A > C > G), or bleomycin (C > T > A > G). The binding of a typical A-T-specific minor-groove binder (netropsin or distamycin A) to DNA strongly inhibits esperamicin-mediated cleavage at 5'-TTC-3', 5'-TTT-3', and 5'-AAA-3' sequences. On the other hand, the binding of EcoRI gives no changes in the sequence-specific cleavage mode of esperamicin. The results suggest that esperamicin interacts with the minor groove of B-DNA. In addition, the trisaccharide side chain appears to be important for binding of esperamicin to DNA.
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